Background: The Roll Back Malaria (RBM) Partnership converged in Abuja in 2000. In 2005, Nigeria adopted artemisinin.based combination therapies (ACTs) as first.line therapy for uncomplicated malaria. It was determinedthat by 2010, 80% of persons with malaria would be effectively treated.Objectives: To describe household practices for malaria treatment in Benin City; to explore demographic characteristics that may influence use of ACTs.Materials and Methods: Multistage sampling technique was used to select households from each of the three local government areas in Benin City. Adult respondents were interviewed. Household reference persons (HRPs)were defined by International Labour Organization categories. Data were collected between Decemb...
Abstract: The study was aimed at investigating malaria prevalence and interventions in three sub-urb...
Nigeria, the most populous nation in the Sub-Saharan African region, remains ravaged with a high occ...
BACKGROUND: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatmen...
Background: The study area is Olambe, a fast-growing community in Ogun State, Nigeria. It shares the...
Malaria still constitutes a public health problem in Nigeria and it is the leading cause of morbidit...
Nigeria, the most populous nation in the Sub-Saharan African region, remains ravaged with a high occ...
This study was carried out in health institutions in Ogun State to evaluate the rational use of arte...
BACKGROUND: At primary care facilities in Nigeria, national treatment guidelines state that malaria ...
In Nigeria, the change from chloroquine and other antimalarial monotherapy treatment to artemisininb...
Magister Public Health - MPHMalaria is a health, social and economic burden in Nigeria and consisten...
Abstract Background: Malaria accounts for 60% of outpatient visits in Nigeria. The aim of the study...
ABSTRACT: Malaria still constitutes a public health problem in Nigeria and it is the leading cause o...
Introduction: Malaria accounts for 70% of illnesses and 30% of deaths among children under 5 years i...
Background Malaria accounts for 60% of outpatient visits in Nigeria. The aim of the study was to as...
BACKGROUND: Despite the uptake of parasitological testing into policy and practice, appropriate pres...
Abstract: The study was aimed at investigating malaria prevalence and interventions in three sub-urb...
Nigeria, the most populous nation in the Sub-Saharan African region, remains ravaged with a high occ...
BACKGROUND: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatmen...
Background: The study area is Olambe, a fast-growing community in Ogun State, Nigeria. It shares the...
Malaria still constitutes a public health problem in Nigeria and it is the leading cause of morbidit...
Nigeria, the most populous nation in the Sub-Saharan African region, remains ravaged with a high occ...
This study was carried out in health institutions in Ogun State to evaluate the rational use of arte...
BACKGROUND: At primary care facilities in Nigeria, national treatment guidelines state that malaria ...
In Nigeria, the change from chloroquine and other antimalarial monotherapy treatment to artemisininb...
Magister Public Health - MPHMalaria is a health, social and economic burden in Nigeria and consisten...
Abstract Background: Malaria accounts for 60% of outpatient visits in Nigeria. The aim of the study...
ABSTRACT: Malaria still constitutes a public health problem in Nigeria and it is the leading cause o...
Introduction: Malaria accounts for 70% of illnesses and 30% of deaths among children under 5 years i...
Background Malaria accounts for 60% of outpatient visits in Nigeria. The aim of the study was to as...
BACKGROUND: Despite the uptake of parasitological testing into policy and practice, appropriate pres...
Abstract: The study was aimed at investigating malaria prevalence and interventions in three sub-urb...
Nigeria, the most populous nation in the Sub-Saharan African region, remains ravaged with a high occ...
BACKGROUND: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatmen...